Leveraging Cardiovascular Simulations for In-Vivo Prediction of Cardiac Biomarkers
Fuente:
arXiv
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Preprint |
| Publicado: |
2024
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1866909439141871616 |
|---|---|
| author | Manduchi, Laura Wehenkel, Antoine Behrmann, Jens Pegolotti, Luca Miller, Andy C. Sener, Ozan Cuturi, Marco Sapiro, Guillermo Jacobsen, Jörn-Henrik |
| author_facet | Manduchi, Laura Wehenkel, Antoine Behrmann, Jens Pegolotti, Luca Miller, Andy C. Sener, Ozan Cuturi, Marco Sapiro, Guillermo Jacobsen, Jörn-Henrik |
| contents | Whole-body hemodynamics simulators, which model blood flow and pressure waveforms as functions of physiological parameters, are now essential tools for studying cardiovascular systems. However, solving the corresponding inverse problem of mapping observations (e.g., arterial pressure waveforms at specific locations in the arterial network) back to plausible physiological parameters remains challenging. Leveraging recent advances in simulation-based inference, we cast this problem as statistical inference by training an amortized neural posterior estimator on a newly built large dataset of cardiac simulations that we publicly release. To better align simulated data with real-world measurements, we incorporate stochastic elements modeling exogenous effects. The proposed framework can further integrate in-vivo data sources to refine its predictive capabilities on real-world data. In silico, we demonstrate that the proposed framework enables finely quantifying uncertainty associated with individual measurements, allowing trustworthy prediction of four biomarkers of clinical interest--namely Heart Rate, Cardiac Output, Systemic Vascular Resistance, and Left Ventricular Ejection Time--from arterial pressure waveforms and photoplethysmograms. Furthermore, we validate the framework in vivo, where our method accurately captures temporal trends in CO and SVR monitoring on the VitalDB dataset. Finally, the predictive error made by the model monotonically increases with the predicted uncertainty, thereby directly supporting the automatic rejection of unusable measurements. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2412_17542 |
| institution | arXiv |
| publishDate | 2024 |
| record_format | arxiv |
| spellingShingle | Leveraging Cardiovascular Simulations for In-Vivo Prediction of Cardiac Biomarkers Manduchi, Laura Wehenkel, Antoine Behrmann, Jens Pegolotti, Luca Miller, Andy C. Sener, Ozan Cuturi, Marco Sapiro, Guillermo Jacobsen, Jörn-Henrik Machine Learning Computational Engineering, Finance, and Science Biological Physics Whole-body hemodynamics simulators, which model blood flow and pressure waveforms as functions of physiological parameters, are now essential tools for studying cardiovascular systems. However, solving the corresponding inverse problem of mapping observations (e.g., arterial pressure waveforms at specific locations in the arterial network) back to plausible physiological parameters remains challenging. Leveraging recent advances in simulation-based inference, we cast this problem as statistical inference by training an amortized neural posterior estimator on a newly built large dataset of cardiac simulations that we publicly release. To better align simulated data with real-world measurements, we incorporate stochastic elements modeling exogenous effects. The proposed framework can further integrate in-vivo data sources to refine its predictive capabilities on real-world data. In silico, we demonstrate that the proposed framework enables finely quantifying uncertainty associated with individual measurements, allowing trustworthy prediction of four biomarkers of clinical interest--namely Heart Rate, Cardiac Output, Systemic Vascular Resistance, and Left Ventricular Ejection Time--from arterial pressure waveforms and photoplethysmograms. Furthermore, we validate the framework in vivo, where our method accurately captures temporal trends in CO and SVR monitoring on the VitalDB dataset. Finally, the predictive error made by the model monotonically increases with the predicted uncertainty, thereby directly supporting the automatic rejection of unusable measurements. |
| title | Leveraging Cardiovascular Simulations for In-Vivo Prediction of Cardiac Biomarkers |
| topic | Machine Learning Computational Engineering, Finance, and Science Biological Physics |
| url | https://arxiv.org/abs/2412.17542 |